
Merck Opens New Facility to Boost Vaccine Production Capacity
Merck Opens New Facility to Boost Vaccine Production Capacity Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has officially opened a new $1 billion, 225,000-square-foot facility dedicated to vaccine manufacturing at its Durham, North Carolina,…












